Othera Pharmaceuticals Overview
- Year Founded
-
2002
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Othera Pharmaceuticals General Information
Description
Developer of proprietary ophthalmic drugs. The company offers products such as OT-551 for geographic atrophy and dry age related macular degeneration and OT-440, a neuroprotectant for glaucoma.
Contact Information
Website
www.othera.comCorporate Office
- Four Tower Bridge
- 200 Barr Harbor Drive, Suite 400
- Conshohocken, PA 19428
- United States
Corporate Office
- Four Tower Bridge
- 200 Barr Harbor Drive, Suite 400
- Conshohocken, PA 19428
- United States
Othera Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 19-Sep-2012 | Completed | Generating Revenue | |||
| 4. Debt - General | 04-Aug-2009 | Completed | Generating Revenue | |||
| 3. Debt - General | 26-Sep-2007 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 22-Oct-2004 | $16M | $16.4M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 17-Oct-2002 | $371K | $371K | Completed | Product Development |
Othera Pharmaceuticals Patents
Othera Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2007100623-A2 | Hydroxylamines and derivatives for the inhibition of complement activation | Inactive | 22-Feb-2006 | ||
| WO-2007100624-A2 | Hydroxylamines and derivatives for treatment of inflammatory conditions of the liver | Inactive | 22-Feb-2006 | ||
| WO-2007100624-A3 | Hydroxylamines and derivatives for treatment of inflammatory conditions of the liver | Inactive | 22-Feb-2006 | ||
| WO-2006127592-A2 | Use of hydroxylamine derivates for inhibiting vitrectomy-induced cataracts | Inactive | 26-May-2005 | ||
| WO-2006127592-A3 | Use of hydroxylamine derivates for inhibiting vitrectomy-induced cataracts | Inactive | 26-May-2005 | A61K31/133 |
Othera Pharmaceuticals Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ben Franklin Technology Partners of Southeastern Pennsylvania | Accelerator/Incubator | Minority | ||
| Commerce Health Ventures | Venture Capital | Minority | ||
| Fletcher Spaght Ventures | Venture Capital | Minority | ||
| Johnson & Johnson JJDC | Corporate Venture Capital | Minority | ||
| NewSpring Capital | Growth/Expansion | Minority |
Othera Pharmaceuticals FAQs
-
When was Othera Pharmaceuticals founded?
Othera Pharmaceuticals was founded in 2002.
-
Where is Othera Pharmaceuticals headquartered?
Othera Pharmaceuticals is headquartered in Conshohocken, PA.
-
What industry is Othera Pharmaceuticals in?
Othera Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Othera Pharmaceuticals a private or public company?
Othera Pharmaceuticals is a Private company.
-
What is Othera Pharmaceuticals’s current revenue?
The current revenue for Othera Pharmaceuticals is .
-
How much funding has Othera Pharmaceuticals raised over time?
Othera Pharmaceuticals has raised $34M.
-
Who are Othera Pharmaceuticals’s investors?
Ben Franklin Technology Partners of Southeastern Pennsylvania, Commerce Health Ventures, Fletcher Spaght Ventures, Johnson & Johnson JJDC, and NewSpring Capital are 5 of 6 investors who have invested in Othera Pharmaceuticals.
-
When was Othera Pharmaceuticals acquired?
Othera Pharmaceuticals was acquired on 19-Sep-2012.
-
Who acquired Othera Pharmaceuticals?
Othera Pharmaceuticals was acquired by Colby Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
